Under the five-year agreement, Micron will be the sole producer of New Era Orthopaedics’ Food and Drug Administration-approved orthopedic implant designs. Micron is expected to be fulfilling orders for New Era in the latter half of 2015.
“Our knee system is based on proven design principles for implants and instrumentation. Importantly, our innovative ‘high flex’ options for cruciate retaining, posterior stabilized and ultra congruent designs provide physicians with the flexibility to address the majority of indications presented. NEO’s knee systems are designed to increase flexion stability while optimizing patellar tracking, rollback and rotation and also focus on minimizing lateral retinacular tightness. We have been most impressed with Micron’s speed and agility, as well as their quality of service as a contract manufacturer. We look forward to a long and mutually beneficial relationship,” Craig Corrance, president and CEO of New Era Orthopaedics.
More articles on devices:
Amedica’s 2014 revenue to hit $22M to $24M — 6 things to know
Sonoma Orthopedic Products receives $12M in financing round
THINK Surgical’s surgical system for THA receives FDA approval
